Update

U.K. Economy Grew 0.7% in Third Quarter, Matching Median Forecast
Tweet TWEET

Mead Johnson Board of Directors Declares Dividend

  Mead Johnson Board of Directors Declares Dividend

Business Wire

GLENVIEW, Ill. -- June 13, 2013

Mead Johnson Nutrition Company (NYSE: MJN) announced today that its board of
directors has declared a regular quarterly dividend of $0.34 per share for the
quarter ending June 30, 2013.

The dividend will be paid on July 5, 2013, to shareholders of record at close
of business on June 24, 2013.

About Mead Johnson

Mead Johnson, a global leader in pediatric nutrition, develops, manufactures,
markets and distributes more than 70 products in over 50 markets worldwide.
The company’s mission is to nourish the world’s children for the best start in
life. The Mead Johnson name has been associated with science-based pediatric
nutrition products for over 100 years. The company’s “Enfa” family of brands,
including Enfamil^® infant formula, is the world’s leading brand franchise in
pediatric nutrition. For more information, visit meadjohnson.com.

Forward-Looking Statements

Certain statements in this news release are forward-looking as defined in the
Private Securities Litigation Reform Act of 1995. These forward-looking
statements may be identified by the fact they use words such as “should,”
“expect,” “anticipate,” “estimate,” “target,” “may,” “project,” “guidance,”
“intend,” “plan,” “believe” and other words and terms of similar meaning and
expression. Such statements are likely to relate to, among other things, a
discussion of goals, plans and projections regarding financial position,
results of operations, cash flows, market position, product development,
product approvals, sales efforts, expenses, capital expenditures, performance
or results of current and anticipated products and the outcome of
contingencies such as legal proceedings and financial results. Forward-looking
statements can also be identified by the fact that they do not relate strictly
to historical or current facts. Such forward-looking statements are based on
current expectations that involve inherent risks, uncertainties and
assumptions that may cause actual results to differ materially from
expectations as of the date of this news release. These risks include, but are
not limited to: (1) the ability to sustain brand strength, particularly the
Enfa family of brands; (2) the effect on the company's reputation of real or
perceived quality issues; (3) the effect of regulatory restrictions related to
the company’s products; (4) the adverse effect of commodity costs; (5)
increased competition from branded, private label, store and economy-branded
products; (6) the effect of an economic downturn on consumers' purchasing
behavior and customers' ability to pay for product; (7) inventory reductions
by customers; (8) the adverse effect of changes in foreign currency exchange
rates; (9) the effect of changes in economic, political and social conditions
in the markets where we operate; (10) changing consumer preferences; (11) the
possibility of changes in the Women, Infant and Children (WIC) program, or
participation in WIC; (12) legislative, regulatory or judicial action that may
adversely affect the company's ability to advertise its products or maintain
product margins; and (13) the ability to develop and market new, innovative
products. For additional information regarding these and other factors, see
the company’s filings with the United States Securities and Exchange
Commission (the “SEC”), including its most recent Annual Report on Form 10-K,
which filings are available upon request from the SEC or at
www.meadjohnson.com. The company cautions readers not to place undue reliance
on any forward-looking statements, which speak only as of the date made. The
company undertakes no obligation to publicly update any forward-looking
statement, whether as a result of new information, future events or otherwise.

Contact:

Mead Johnson Nutrition Company
Investors:
Kathy MacDonald, (847) 832-2182
kathy.macdonald@mjn.com
or
Media:
Christopher Perille, (847) 832-2178
chris.perille@mjn.com
 
Press spacebar to pause and continue. Press esc to stop.